Product Reports Resources Pricing Login Book a demo

Oxford VR

Health Tech & Medtech · Austin, United States · Founded 2017

Transforming mental health for millions with state-of-the-art immersive technology MoreLess

Oxford VR, established in 2016 as a spin-out from the University of Oxford, specializes in developing virtual reality (VR) therapies for serious mental illnesses. The company was co-founded by Professor Daniel Freeman, a clinical psychologist at Oxford's Department of Psychiatry, and Deepak Gopalakrishna. Freeman's journey into VR for mental health stems from over two decades of research into the field, driven by a desire to overcome the shortage of skilled therapists by creating automated, yet effective, psychological treatments.

The core of Oxford VR's business is the creation of automated, evidence-based digital treatments using cognitive behavioral therapy (CBT) principles within immersive VR environments. These programs are designed to be guided by a virtual coach, allowing them to be administered by a range of healthcare staff and increasing patient access to care. The company's business model targets healthcare providers, such as the UK's National Health Service (NHS) and other mental healthcare organizations, offering a cost-effective and scalable solution to traditional therapy. Clients include entities like the NHS, AXA, and Universal Health Services.

One of the company's notable products is an automated VR treatment for the fear of heights, which demonstrated significant clinical benefits in trials published in The Lancet Psychiatry. Another key product, gameChange, is a VR therapy designed for patients with psychosis, which helps them overcome anxious social avoidance. This product received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The therapies place users in simulations of environments that trigger their symptoms, such as a crowded train or a high-rise building, where they receive live coaching to process their conditions in a safe space. In late 2022, Oxford VR merged with the U.S.-based company BehaVR to expand its reach and capabilities, particularly in the United States, operating under the BehaVR brand.

Keywords: digital therapeutics, virtual reality therapy, mental health treatment, cognitive behavioral therapy, psychosis, anxious social avoidance, phobia treatment, digital health, health tech, automated therapy, immersive technology, serious mental illness, clinical psychology, patient management platform, telehealth, gameChange, BehaVR, Daniel Freeman, digital wellness, behavioral health

Talent graph

Oxford VR's talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Oxford VR's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Oxford Science Enterprises
Force Over Mass Capital
Series A 5 investors entered at this stage
GT Healthcare
RT Ventures
Optum Ventures
Oxford University Innovation
Luminous Ventures

Global footprint

Where Oxford VR has talent and traffic

Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown

Market sentiment

What the market is saying about Oxford VR

An AI-synthesized read of the highest-engagement posts about Oxford VR on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oxford VR on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.